| scholarly article | Q13442814 |
| P2093 | author name string | Neveen Said | |
| Bincy Anu John | |||
| P2860 | cites work | Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy | Q21131727 |
| RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration | Q24608385 | ||
| Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer | Q24623746 | ||
| COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer | Q24644945 | ||
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | Q24657020 | ||
| Murine models to evaluate novel and conventional therapeutic strategies for cancer | Q24673595 | ||
| Advances in imaging technologies in the evaluation of high-grade bladder cancer | Q26852856 | ||
| Standards for Cell Line Authentication and Beyond | Q27342403 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Cre recombinase: the universal reagent for genome tailoring | Q28145361 | ||
| A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene | Q28279136 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer | Q28328584 | ||
| Susceptibility of urothelium to neoplastic cellular implantation | Q28338312 | ||
| Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat | Q28362621 | ||
| Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype | Q28395447 | ||
| Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice | Q28550059 | ||
| Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. | Q28730032 | ||
| Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay | Q29036920 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| Systematic identification of genomic markers of drug sensitivity in cancer cells | Q29547695 | ||
| Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine | Q30160400 | ||
| A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model. | Q30375752 | ||
| CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization | Q30408689 | ||
| Loss of SPARC in bladder cancer enhances carcinogenesis and progression | Q30422650 | ||
| Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination | Q30439008 | ||
| Molecular credentialing of rodent bladder carcinogenesis models | Q30441327 | ||
| Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach | Q30455697 | ||
| Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging. | Q30880452 | ||
| Dual-track pathway of bladder carcinogenesis: practical implications | Q33245390 | ||
| Primary uroepithelial cultures. A model system to analyze umbrella cell barrier function. | Q33636097 | ||
| Xenografts of human bladder cancer in immune-deprived mice | Q70252377 | ||
| Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. I. Histology | Q70412985 | ||
| Urothelial susceptibility to tumor cell implantation: influence of cauterization | Q70721796 | ||
| The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma | Q72394546 | ||
| Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation | Q73897079 | ||
| Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities | Q77302931 | ||
| Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49) | Q77347134 | ||
| Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma | Q78029755 | ||
| A new method of implanting orthotopic rat bladder tumor for experimental therapies | Q78419992 | ||
| SELECTIVE INDUCTION OF BLADDER CANCER IN RATS BY DIBUTYL- AND N-BUTYL-N-BUTANOL(4)-NITROSAMINE | Q78503117 | ||
| Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder | Q78762243 | ||
| A novel intravesical therapy for superficial bladder cancer in an orthotopic model: oncolytic reovirus therapy | Q80995132 | ||
| Bladder cancer | Q84058686 | ||
| Bladder cancer | Q86591216 | ||
| Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer | Q87126660 | ||
| Familial and environmental interactions in bladder cancer risk | Q93575245 | ||
| Effects of stones and other physical factors on the induction of rodent bladder cancer | Q40413192 | ||
| The hollow fiber assay: continued characterization with novel approaches. | Q40879986 | ||
| In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation | Q41158583 | ||
| Heterotransplantation of Human Transitional Cell Carcinoma in Athymic Mice | Q41456812 | ||
| Modulation of Doxorubicin sensitivity and level of p-glycoprotein expression in human colon-carcinoma cells by ectopic and orthotopic environments in nude-mice. | Q41528602 | ||
| Urinary bladder carcinogenesis | Q41720983 | ||
| K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder. | Q41788062 | ||
| Development and characterization of efficient xenograft models for benign and malignant human prostate tissue | Q42473593 | ||
| Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? | Q42628372 | ||
| Bladder cancer xenografts: a model of tumor cell heterogeneity | Q42812552 | ||
| Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. | Q44044170 | ||
| Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. | Q44732070 | ||
| Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model | Q45526738 | ||
| Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer | Q45875957 | ||
| AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model | Q45889278 | ||
| Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study | Q46505618 | ||
| Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner | Q46952728 | ||
| Real-time in vivo photoacoustic and ultrasound imaging | Q47226500 | ||
| Speed-of-sound compensated photoacoustic tomography for accurate imaging. | Q51289123 | ||
| Anti-angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus Calmette-Guérin immunotherapy for nonmuscle invasive bladder cancer. | Q51375037 | ||
| Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma. | Q51527552 | ||
| Intravesical ultrasonography for tumor staging in an orthotopically implanted rat model of bladder cancer. | Q51766809 | ||
| Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. | Q52212326 | ||
| The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma. | Q53284850 | ||
| Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue. | Q53342271 | ||
| Bladder cancer risk and personal hair dye use. | Q53370388 | ||
| p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. | Q53452635 | ||
| Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits. | Q53537196 | ||
| [Quenched fluorescein: a reference dye for instrument response function of TCSPC]. | Q53670859 | ||
| Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics | Q54336157 | ||
| Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients. | Q54583947 | ||
| Segregation analysis of urothelial cell carcinoma | Q57307262 | ||
| Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine | Q67782654 | ||
| Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models | Q34310234 | ||
| Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma | Q34338401 | ||
| Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells. | Q34358867 | ||
| First- and second-line therapy for metastatic urothelial carcinoma of the bladder | Q34541463 | ||
| Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes | Q34544350 | ||
| β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. | Q34603174 | ||
| Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder | Q34629260 | ||
| A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. | Q34717264 | ||
| Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia | Q34994908 | ||
| Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis | Q35006427 | ||
| Comparative pathology of proliferative lesions of the urinary bladder | Q35038992 | ||
| Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma | Q35063395 | ||
| Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors | Q35077800 | ||
| Modelling bladder cancer in mice: opportunities and challenges | Q35285703 | ||
| An orthotopic model of murine bladder cancer | Q35396341 | ||
| Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas | Q35612218 | ||
| Three differentiation states risk-stratify bladder cancer into distinct subtypes | Q35750975 | ||
| Focus on bladder cancer | Q35868630 | ||
| Bladder cancer, a review of the environmental risk factors. | Q36072492 | ||
| Urothelial tumorigenesis: a tale of divergent pathways | Q36234720 | ||
| Advantages of multi-color fluorescent proteins for whole-body and in vivo cellular imaging | Q36264458 | ||
| Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer | Q36265124 | ||
| Experimental models of human bladder carcinogenesis. | Q36313029 | ||
| Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression | Q36439816 | ||
| Experimental bladder carcinogenesis-rodent models. | Q36449191 | ||
| Knockout of phospholipase Cε attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis | Q36624048 | ||
| Tumor microenvironment: the role of the tumor stroma in cancer | Q36709404 | ||
| Risk factors for bladder cancer. | Q36800382 | ||
| A new method of establishing orthotopic bladder transplantable tumor in mice | Q36814459 | ||
| Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer | Q36823607 | ||
| Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial | Q36922024 | ||
| Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior | Q36945929 | ||
| A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience | Q36979001 | ||
| Experimental models for therapeutic studies of transitional cell carcinoma. | Q36985572 | ||
| Clinical states model for biomarkers in bladder cancer | Q36995765 | ||
| History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story | Q36998789 | ||
| Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression | Q37016565 | ||
| Inactivation of p53 and Pten promotes invasive bladder cancer | Q37141814 | ||
| An Efficient Light-Inducible P53 Expression System for Inhibiting Proliferation of Bladder Cancer Cell | Q37348715 | ||
| Experimental animal model and RNA interference: a promising association for bladder cancer research. | Q37392045 | ||
| Mouse orthotopic models for bladder cancer research | Q37457056 | ||
| Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer | Q37460949 | ||
| Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. | Q37480033 | ||
| The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer. | Q37647214 | ||
| Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression | Q37770783 | ||
| Urothelial carcinoma of the bladder: definition, treatment and future efforts | Q37944437 | ||
| Biomedical applications of photoacoustic imaging with exogenous contrast agents. | Q37952116 | ||
| Bioluminescence imaging: looking beyond the light. | Q37982886 | ||
| Review: BBN as an urothelial carcinogen | Q38024772 | ||
| Current preclinical models for the advancement of translational bladder cancer research | Q38069907 | ||
| Management of superficial and muscle-invasive urothelial cancers of the bladder | Q38083129 | ||
| EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. | Q38119345 | ||
| Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma (TCC)--avoidance, recognition, management and consent | Q38140054 | ||
| The mechanism of action of BCG therapy for bladder cancer--a current perspective | Q38184849 | ||
| Inducible gene knockouts in the small intestinal and colonic epithelium | Q38317150 | ||
| p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. | Q38345714 | ||
| Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model | Q38522626 | ||
| Tumor imaging technologies in mouse models | Q38914890 | ||
| Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells | Q39200090 | ||
| Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients. | Q39363055 | ||
| The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer | Q39605867 | ||
| Investigating the effect of longitudinal micro-CT imaging on tumour growth in mice | Q39619704 | ||
| Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro | Q39656364 | ||
| Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer | Q39836117 | ||
| Intravesical and systemic chemotherapy of murine bladder cancer | Q39863123 | ||
| Histopathological characterization of a syngeneic orthotopic murine bladder cancer model. | Q39984765 | ||
| Newly developed mini-endoscope for diagnosis and follow-up of orthotopic bladder transitional-cell carcinoma in vivo | Q40092303 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 57766-57781 | |
| P577 | publication date | 2017-05-09 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Insights from animal models of bladder cancer: recent advances, challenges, and opportunities | |
| P478 | volume | 8 |
| Q59127377 | Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility |
| Q92487496 | Bladder organoids: a step towards personalised cancer therapy? |
| Q64259325 | Enhanced metastatic potential in the MB49 urothelial carcinoma model |
| Q92487512 | Establishing and characterization of human and murine bladder cancer organoids |
| Q41037577 | Hurdles in Basic Science Translation |
| Q58554809 | IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway |
| Q98771470 | Mechanisms of Macrophage Immunomodulatory Activity Induced by a New Polysaccharide Isolated From Polyporus umbellatus (Pers.) Fries |
| Q55397522 | Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. |
| Q90221264 | The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology |
| Q91312557 | Xenografting for disease modeling of intramedullary spinal cord tumors: a systematic review |
Search more.